Early Detection of Mild Cognitive Impairment in Individual Patients
Completed
Conditions studied: Mild Cognitive Impairment, Mild Alzheimer's Disease
In brief
Our central hypothesis is that the early metabolic lesions of MCI can be reliably detected in individual subjects by objective analysis of \[18\]F-fluorodeoxyglucose (FDG) positron-emission tomography (PET) brain images, earlier and more accurately than by subjective clinician rating.
Key facts
- Study ID
- NCT00243451
- Run by
- Louisiana State University Health Sciences Center Shreveport
- People needed
- 34
- Starts
- 2003-09-01
- Expected to finish
- 2011-07-01
- Last updated by the study team
- 2011-09-07
Who can join
Age: 55 and older, up to 85. Sex: any. Healthy volunteers: accepted.
Where it is running
- Louisiana State University Health Sciences Center — Shreveport, Louisiana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.